Product Information
ARFORMOTEROL 15 MCG/2 ML SOLN is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.6202 per ML under NDC 62332063360. Its NADAC has been published 146 times since Dec 20, 2023.
FDA first approved this application on May 10, 2022. Its Orange Book therapeutic-equivalence code is AN.
Strength
15 ug/2mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332063360
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ARFORMOTEROL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214779FDA Approved
5/10/2022
TE Code
AN
On Market Since
5/10/2022
Pharmacological Classes
Price Statistics
The NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has been published 146 times since Dec 20, 2023, and over the history we have for it it has declined 65.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6202 per ML |
|---|---|
| All-time high | $1.7884 (Jan 10, 2024) |
| All-time low | $0.6202 (Sep 23, 2026) |
| 52-week high | $0.7666 |
| 52-week low | $0.6202 |
| Median price | $0.7661 |
| Average price | $0.9051 |
| Largest weekly change | -38.4% (Nov 20, 2024) |
| Weeks tracked | 146 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Arformoterol tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARFORMOTEROL 15 MCG/2 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ARFORMOTEROL 15 MCG/2 ML SOLN, manufactured by Alembic Pharmaceuticals Inc., is $0.6202 per ML (NDC 62332063360), effective Sep 30, 2026.
How has the price of ARFORMOTEROL 15 MCG/2 ML SOLN changed over time?
Over the history we have for it, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has declined 65.3%. It has been tracked across 146 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for ARFORMOTEROL 15 MCG/2 ML SOLN?
Since Dec 20, 2023, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has ranged from a low of $0.6202 (Sep 23, 2026) to a high of $1.7884 (Jan 10, 2024), with a median of $0.7661 per ML.
Are there cheaper alternatives to ARFORMOTEROL 15 MCG/2 ML SOLN?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARFORMOTEROL 15 MCG/2 ML SOLN, is $0.6145 per ML — about 1% below ARFORMOTEROL 15 MCG/2 ML SOLN.
Who manufactures ARFORMOTEROL 15 MCG/2 ML SOLN?
ARFORMOTEROL 15 MCG/2 ML SOLN (NDC 62332063360) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.